Following the onset of the pandemic, the Indian pharma industry has shown its role as a reliable supplier of drugs and medical devices in a time of need, D V Sadananda Gowda added.
Synopsis
Pharmaceuticals are one of the top-10 attractive sectors for foreign investment in India. FDI inflows in the pharmaceuticals sector reached Rs 3,650 crore in 2019-20, recording a growth of 98 per cent year-on-year, he added.
He was addressing the curtain raiser press conference on the 6th edition of Indian Pharma & India Medical Device 2021 .
New Delhi: The Indian pharmaceutical industry has proved to be a dependable supplier of quality drugs in a time of global need on account of the COVID-19 pandemic, and is expected to reach a size of USD 130 billion by 2030, Chemical and Fertiliser Minister D V Sadananda Gowda said on Monday. Following the onset of the pandemic, the Indian pharma industry has shown its role as a reliable supplier of drugs and medical devices in a time of need, he added.